BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

9673

540937

MEDICO

img img img img
No Data Available

MEDICO REMEDIES LIMITED performance

Today’s low

Today’s high

₹ 50.00 ₹ 52.40
₹ 52.11

52 week low

52 week high

₹ 37.18 ₹ 79.83
₹ 52.11

Open Price

₹ 51.50

Prev. Close

₹ 50.16

Volume (Shares)

218804.00

Total traded value

₹ 114.01

Upper Circuit

₹ 52.66

Lower Circuit

₹ 47.65

info

MEDICO REMEDIES LIMITED Share Price Update

As of the latest trading session, MEDICO REMEDIES LIMITED share price is currently at ₹ 52.4, which is up by ₹ 2.24 from its previous closing. Today, the stock has fluctuated between ₹ 50.00 and ₹ 52.40. Over the past year, MEDICO REMEDIES LIMITED has achieved a return of 8.08 %. In the last month alone, the return has been 8.06 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

MEDICO REMEDIES LIMITED fundamentals


  • Market cap (Cr)

    432.40

  • P/E Ratio (TTM)

    38.07

  • Beta

    0.28

  • Book Value / share

    8.05

  • Return on equity

    17.57%

  • EPS (TTM)

    1.37

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    2.57

info icon alternate text
  • Market cap (Cr)

    432.80

  • P/E Ratio (TTM)

    38.07

  • Beta

    0.20

  • Book Value / share

    8.05

  • Return on equity

    17.57%

  • EPS (TTM)

    1.37

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    2.57

info icon alternate text

MEDICO REMEDIES LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 52.64
Operating Expense 50.89
Net Profit 2.57
Net Profit Margin (%) 4.88
Earnings Per Share (EPS) 0.31
EBITDA 4.43
Effective Tax Rate (%) 26.22
Particulars JUN 2025 (Values in Cr)
Revenue 38.25
Operating Expense 36.47
Net Profit 1.82
Net Profit Margin (%) 4.75
Earnings Per Share (EPS) 0.22
EBITDA 3.48
Effective Tax Rate (%) 25.51
Particulars MAR 2025 (Values in Cr)
Revenue 41.30
Operating Expense 35.89
Net Profit 4.34
Net Profit Margin (%) 10.50
Earnings Per Share (EPS) 0.52
EBITDA 6.96
Effective Tax Rate (%) 23.85
Particulars DEC 2024 (Values in Cr)
Revenue 39.49
Operating Expense 37.42
Net Profit 2.62
Net Profit Margin (%) 6.63
Earnings Per Share (EPS) 0.32
EBITDA 4.54
Effective Tax Rate (%) 25.14
Particulars SEP 2024 (Values in Cr)
Revenue 39.35
Operating Expense 37.89
Net Profit 1.55
Net Profit Margin (%) 3.93
Earnings Per Share (EPS) 0.19
EBITDA 3.09
Effective Tax Rate (%) 27.23
Particulars MAR 2025 (Values in Cr)
Revenue 150.94
Operating Expense 140.13
Net Profit 10.09
Net Profit Margin (%) 6.68
Earnings Per Share (EPS) 1.22
EBITDA 17.69
Effective Tax Rate (%) 25.25
Particulars MAR 2024 (Values in Cr)
Revenue 144.92
Operating Expense 135.70
Net Profit 8.29
Net Profit Margin (%) 5.72
Earnings Per Share (EPS) 1.00
EBITDA 15.03
Effective Tax Rate (%) 26.83
Particulars MAR 2023 (Values in Cr)
Revenue 140.44
Operating Expense 134.29
Net Profit 7.24
Net Profit Margin (%) 5.15
Earnings Per Share (EPS) 0.87
EBITDA 13.57
Effective Tax Rate (%) 28.31
Particulars MAR 2022 (Values in Cr)
Revenue 121.02
Operating Expense 116.56
Net Profit 4.81
Net Profit Margin (%) 3.97
Earnings Per Share (EPS) 2.90
EBITDA 9.36
Effective Tax Rate (%) 25.77
Particulars MAR 2021 (Values in Cr)
Revenue 122.39
Operating Expense 119.73
Net Profit 2.59
Net Profit Margin (%) 2.11
Earnings Per Share (EPS) 6.25
EBITDA 6.26
Effective Tax Rate (%) 29.53
Particulars MAR 2025 (Values in Cr)
Book Value / Share 7.53
ROE % 17.57
ROCE % 21.31
Total Debt to Total Equity 0.20
EBITDA Margin 11.72
Particulars MAR 2024 (Values in Cr)
Book Value / Share 6.31
ROE % 17.23
ROCE % 21.24
Total Debt to Total Equity 0.19
EBITDA Margin 10.37
Particulars MAR 2023 (Values in Cr)
Book Value / Share 5.28
ROE % 18.00
ROCE % 21.01
Total Debt to Total Equity 0.28
EBITDA Margin 9.66
Particulars MAR 2022 (Values in Cr)
Book Value / Share 22.04
ROE % 13.93
ROCE % 14.74
Total Debt to Total Equity 0.40
EBITDA Margin 7.73
Particulars MAR 2021 (Values in Cr)
Book Value / Share 78.22
ROE % 8.31
ROCE % 10.11
Total Debt to Total Equity 0.46
EBITDA Margin 5.12
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.09
Total Assets 119.79
Total Liabilities 119.79
Total Equity 62.46
Share Outstanding 82984000
Price to Book Ratio 6.92
Return on Assets (%) 8.42
Return on Capital (%) 13.23
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.18
Total Assets 96.19
Total Liabilities 96.19
Total Equity 52.37
Share Outstanding 82984000
Price to Book Ratio 7.81
Return on Assets (%) 8.61
Return on Capital (%) 14.02
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.91
Total Assets 87.44
Total Liabilities 87.44
Total Equity 43.84
Share Outstanding 82984000
Price to Book Ratio 14.15
Return on Assets (%) 8.28
Return on Capital (%) 13.94
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.34
Total Assets 77.40
Total Liabilities 77.40
Total Equity 36.57
Share Outstanding 16596800
Price to Book Ratio 3.81
Return on Assets (%) 6.21
Return on Capital (%) 10.2
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.83
Total Assets 75.62
Total Liabilities 75.62
Total Equity 32.46
Share Outstanding 4149200
Price to Book Ratio 1.28
Return on Assets (%) 3.42
Return on Capital (%) 5.45
Particulars MAR 2025 (Values in Cr)
Net Income 13.50
Cash from Operations 8.69
Cash from Investing -3.45
Cash from Financing -0.52
Net change in Cash 0.91
Free Cash Flow 8.69
Particulars MAR 2024 (Values in Cr)
Net Income 11.33
Cash from Operations 5.60
Cash from Investing -2.67
Cash from Financing -0.49
Net change in Cash -0.72
Free Cash Flow 5.60
Particulars MAR 2023 (Values in Cr)
Net Income 10.09
Cash from Operations 10.66
Cash from Investing -6.60
Cash from Financing -1.81
Net change in Cash -0.25
Free Cash Flow 10.66
Particulars MAR 2022 (Values in Cr)
Net Income 6.48
Cash from Operations 7.65
Cash from Investing -1.75
Cash from Financing -5.77
Net change in Cash -1.66
Free Cash Flow 7.65
Particulars MAR 2021 (Values in Cr)
Net Income 2.59
Cash from Operations -10.38
Cash from Investing -16.96
Cash from Financing 18.28
Net change in Cash -9.99
Free Cash Flow 6.58
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 28.40 13.92 1.47 217.64 28.26 / 68.00
BLISS GVS PHARMA LTD 166.25 16.03 1.55 1757.64 105.05 / 190.65
CIPLA LTD 1530.95 22.73 3.75 123665.73 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 282.65 7.43 2.12 831.87 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2566.65 45.61 25.46 43480.60 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 28.40 23.09 3.95 217.64 28.26 / 68.00
AMRUTAJAN HEALTH LTD 682.00 34.78 5.76 1971.70 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9048.30 97.85 28.31 22620.75 6301.00 / 10653.05
BLISS GVS PHARMA LTD 166.25 22.44 1.59 1757.64 105.05 / 190.65

MEDICO REMEDIES LIMITED shareholding pattern

Holding

38.3%
61.38%
0.3%
0.01%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

News

Left Arrow
Right Arrow

MEDICO REMEDIES LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
52.11 3.88 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 50.70
  • 26 Days 50.30
  • 10 Days 50.70
  • 50 Days 48.80
  • 12 Days 50.80
  • 100 Days 47.70
  • 20 Days 50.60
  • 200 Days 49.10
49.92 PIVOT

First Support

48.94

First Resistance

51.14

Second Support

47.72

Second Resistance

52.12

Third Support

46.74

Third Resistance

53.34

RSI

58.99

ADX

28.37

MACD

0.47

Williams % R

-29.48

Commodity Channel Index (CCI)

29.55

Date

2025-10-01

Week

662313.00

Same Day

396651.00

Month

292138.00

1 Year

0.28

3 Year

0.36

Over 1 Month

8.06%

down

Over 1 Year

8.08%

down

Over 3 Months

36.44%

down

Over 3 Years

-4.37%

down

Over 6 Months

-3.15%

down

Over 5 Years

0.00%

down

MEDICO REMEDIES LIMITED Corporate Actions

Ex-Date Ex-Bonus Ratio
17 Nov 2021 16 Nov 2021 3:1
Ex-Date Old FV NEW FV Record Date
16 Mar 2023 10.0 2.0 16 Mar 2023
Ex-Date Ex-Bonus Ratio
17 Nov 2021 16 Nov 2021 3:1
Ex-Date Old FV NEW FV Record Date
16 Mar 2023 10.0 2.0 16 Mar 2023

MEDICO REMEDIES LIMITED Share Price

Medico Remedies Limited was incorporated as a Private Limited Company with the name 'Medico Remedies Private Limited' on March 18, 1994. The status was changed to a Public Limited Company and the Company name was changed to Medico Remedies Limited on March 6, 2017.

Medico Remedies is a pharmaceutical formulation manufacturing company with manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics and other supplements. Further in addition to above, the Company also has manufacturing and marketing capabilities in other drugs such as NSAIDS, Antihistaminic, Antidiabetics, Cardio Vascular Drugs, Diuretics, Anti-Epileptics, combination drug kits, syrups and cream & gel for various therapeutic segments.

The Company is ISO 9001:2015 certified for its management system for the manufacture and marketing of pharmaceutical products. It also obtained a WHO-GMP accreditation for the manufacture of its products from the World Health Organisation and has also been certified by Government Recognised Star Exports, Pharmacy and Poison Board, NAFDAC and National Drug Authority, Uganda.

The Company began its operations in 1994 with manufacturing and servicing of diuretics, anti-malarials, NSAIDS tablets, anti-reterovirals, anti-ulcer drugs and anti-acids tablets. Over the years the company has expanded its scale and scope of operations and currently the Company is engaged in manufacture of formulations for various medicines. As part of this expansion, in year 1999 & 2002, Company has a manufacturing facility for the manufacture of its products located in the State of Maharashtra at Palghar.. The plant is divided into two units, i.e. general formulations unit and beta-lactam unit; the beta lactam unit is further divided into two segments -Penicillin and Cephalosporins.

The Company has built a strong relationship with its customers for drug formulations. The clients include Indian as well as foreign pharmaceutical companies like Anphar Limited, Saad Medical, Manfes Pharmaceuticals & Chemical Industries, Award Global Company Limited, Directorate of Health Services (DHS, Maharashtra) to name a few. The Company also earns revenue from the sale of licenses such as FMS license, FPS license and MESI license.

In 2018-19, the Company purchased adjoining manufacturing unit with existing factory at Palghar.

In January 2018, the Company came up with a Public Issue of 10,99,200 Equity Shares by raising equity capital amounting to Rs 10.99 Crores.

Parent organization Indian Private
NSE symbol MEDICO
Founded 1994
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Medico Remedies Ltd?

Answer Field

Medico Remedies Ltd share price is for NSE ₹ 52.40 & for BSE ₹ 52.00 as on Nov 28 2025 03:29 PM.

What is the Market Cap of Medico Remedies Ltd Share?

Answer Field

The market cap of Medico Remedies Ltd for NSE ₹ 432.40 & for BSE ₹ 0.00 as on Nov 28 2025 03:29 PM.

What is the 52 Week High and Low of Medico Remedies Ltd?

Answer Field

The 52 Week High and Low of Medico Remedies Ltd for NSE is ₹ 79.83 and ₹ 37.18 and for BSE is ₹ 79.78 and ₹ 35.00.

What is 1 year return for Medico Remedies Ltd?

Answer Field

The 1 year returns on the stock has been 8.08%.

What is the P/E Ratio of Medico Remedies Ltd Share?

Answer Field

As on Nov 28 2025 03:29 PM the price-to-earnings (PE) ratio for Medico Remedies Ltd share is 38.07.

What is the PB ratio of Medico Remedies Ltd Share?

Answer Field

As on Nov 28 2025 03:29 PM, the price-to-book (PB) ratio for Medico Remedies Ltd share is 8.05.

How to Buy Medico Remedies Ltd Share?

Answer Field

You can trade in Medico Remedies Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Medico Remedies Ltd Share on Bajaj Broking App?

Answer Field

To buy Medico Remedies Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Medico Remedies Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59